Journal Basic Info

  • Impact Factor: 1.809**
  • H-Index: 6
  • ISSN: 2474-1655
  • DOI: 10.25107/2474-1655
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Renal Disease
  •  Oncology Cases
  •  Cardio-Thoracic Surgery
  •  Molecular Biology
  •  Orthopedics & Rheumatology
  •  Veterinary Sciences
  •  Lung Cancer
  •  Trauma

Abstract

Citation: Ann Clin Case Rep. 2022;7(1):2168.DOI: 10.25107/2474-1655.2168

A Case of SARS-CoV-2 Vaccination-Induced Mesenteric Vasculitis Improved by Adalimumab in Ankylosing Spondylitis

Hanna Lee1, Chiyeon Kim2 and Sang-Il Lee3*

1Department of Internal Medicine and Institute of Health Science, Gyeongsang National University School of Medicine and Gyeongsang National University Changwon Hospital, South Korea 2Department of Dermatology and Institute of Health Science, Gyeongsang National University School of Medicine and Gyeongsang National University Changwon Hospital, South Korea 3Department of Internal Medicine and Institute of Health Science, Division of Rheumatology, Gyeongsang National University School of Medicine and Gyeongsang National University Changwon Hospital, South Korea

*Correspondance to: Sang-Il Lee 

 PDF  Full Text Case Report | Open Access

Abstract:

Recently, SARS-CoV-2 vaccines have been reported to increase the incidence of immune-mediated diseases, including systemic vasculitis, in various rheumatic diseases. Herein, we report a case of severe mesenteric vasculitis following administration of an mRNA vaccine (Johnson and Johnson Ad26.COV2.S) in a patient with ankylosing spondylitis. A 49-year-old woman presented with massive hematochezia and multiple erythematous purpuric papules throughout her body after a single-dose inoculation with SARS-CoV-2 vaccine. Mesenteric vasculitis was diagnosed based on clinical investigation, abdominal computed tomography, colonoscopy, and skin biopsy. Her symptoms worsened after high-dose steroid therapy but dramatically responded to adalimumab treatment. The findings from this case suggest a causal relationship between the SARS-CoV-2 vaccine and mesenteric vasculitis, and the therapeutic advantage of TNF-α inhibitors for this severe complication.

Keywords:

Cite the Article:

Lee H, Kim C, Sang-Il Lee. A Case of SARS-CoV-2 Vaccination-Induced Mesenteric Vasculitis Improved by Adalimumab in Ankylosing Spondylitis. Ann Clin Case Rep. 2022; 7: 2168..

Search Our Journal

Journal Indexed In

Articles in PubMed

A New Minimally Invasive Procedure for Muscle, Back, Neck Pain and Radiculopathy - The Myofascial Nerve Block
 PubMed  PMC  PDF  Full Text
Does Autoimmunity have a Role in Myoclonic Astatic Epilepsy? A Case Report of Voltage Gated Potassium Channel Mediated Seizures
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Treatment of Lower Limb Movement Disorder in Complete Paraplegia Caused by Spinal Cord Injury with Spinal Neuromodulation: A Case Report
 PDF  Full Text
Misdiagnosis of an Atypical Creutzfeldt-Jakob Disease: Analysis of One Case in China and Review of the Literature
 Abstract  PDF  Full Text
View More...